MariolaAlejandraVazquez-MartinezMD
Hematology • San Juan, PRHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Mariola Vazquez-Martinez
Dr. Vazquez-Martinez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Ponce de Leon Avenue
San Juan, PR 00919Phone+1 787-758-2000Fax+1 787-771-7593
Summary
- Dr. Mariola Vazquez-Martinez is a hematologist in San Juan, PR and is affiliated with multiple hospitals in the area, including Veterans Affairs Caribbean Healthcare System and H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from Universidad Central del Caribe School of Medicine and has been in practice 1 year. She specializes in hematologic oncology.
Education & Training
San Juan City HospitalFellowship, Hematology and Medical Oncology, 2020 - 2023
Drexel University College of Medicine/Hahnemann University HospitalChief Residency, Internal Medicine, 2018 - 2019- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2016 - 2018
- Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 2015 - 2016
Universidad Central del Caribe School of MedicineClass of 2015
Certifications & Licensure
PR State Medical License 2019 - 2027
PA State Medical License 2015 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsNew Approaches for the Treatment of AML beyond the 7+3 Regimen: Current Concepts and New Approaches.Jaime L Roman Diaz, Mariola Vazquez Martinez, Farhad Khimani
Cancers. 2024-02-05 - Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma.Gliceida Galarza Fortuna, Rahul Banerjee, Constanza Savid-Frontera, Jinming Song, Carlos M Morán-Segura
Blood Cancer Journal. 2024-10-16 - From the Nares to the Bone Marrow: A Role for Transarterial Embolization in an Aberrant Life-Threatening Cause of Epistaxis.Andrew Engel-Rodriguez, Natalie Engel-Rodriguez, Mariola A Vazquez Martinez, William Cáceres-Perkins, Juan Vazquez-Fuster
Cureus. 2022-11-01
Abstracts/Posters
- Teclistamab Induces Favorable Responses in Patients with Relapsed and Refractory Multiple Myeloma after Prior BCMA-Directed TherapyAriel F. Grajales-Cruz, Omar Castaneda, Doris K. Hansen, Mariola A Vazquez-Martinez, Brandon Blue, Sushmita Khadka, Hien Liu, Jose L. Ochoa-Bayona, Ciara Louise L. Fre..., ASH 2023, 11/2/2023
- Autologous Stem Cell Transplant: A Cost Effective and Efficacious Treatment for Newly Diagnosed Multiple MyelomaSeema Niphadkar, DO, Indumathy Varadarajan, MD, Tiffany Pompa, MD, Kevin Y Hou, MD, Kathleen Degen, MD, Mariola Vazquez-Martinez, MD, Stuthi Perimbeti, MD, Kristine Wa..., ASH, 12/2/2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
